The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Federal Register :: Revocation of Emergency Use of a Drug During the COVID 19 Pandemic; Availability Is BPC 157 Legal? Understanding Its Status and Implications Gray Market Peptides: So Much Hype, So Little Data